Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction

Abstract Aims In this study, we estimated the 30 day all‐cause and heart failure‐specific readmission rates, predictors, mortality, and hospitalization costs in patients with obstructive sleep apnoea admitted with acute decompensated heart failure with reduced ejection fraction. Methods and results...

Full description

Bibliographic Details
Main Authors: Don Mathew, Bhanu Kosuru, Siddharth Agarwal, Utsav Shrestha, Akil Sherif
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14430
_version_ 1827891515554267136
author Don Mathew
Bhanu Kosuru
Siddharth Agarwal
Utsav Shrestha
Akil Sherif
author_facet Don Mathew
Bhanu Kosuru
Siddharth Agarwal
Utsav Shrestha
Akil Sherif
author_sort Don Mathew
collection DOAJ
description Abstract Aims In this study, we estimated the 30 day all‐cause and heart failure‐specific readmission rates, predictors, mortality, and hospitalization costs in patients with obstructive sleep apnoea admitted with acute decompensated heart failure with reduced ejection fraction. Methods and results This is a retrospective cohort study using the Agency of Healthcare Research and Quality's National Readmission Database for the year 2019. The primary outcome was the 30 day all‐cause hospital readmission rate. The secondary outcomes were (i) in‐hospital mortality rate for index admissions; (ii) 30 day mortality rate for index hospitalizations; (iii) the five most common principal diagnosis for readmission; (iv) readmission in‐hospital mortality rate; (v) length of hospital stay; (vi) independent risk factors for readmission; and (vii) hospitalization costs. We identified 6908 hospitalizations that met our study definition. The mean patient age was 62.8 years, and women comprised only 27.6% of patients. The 30 day all‐cause readmission rate was 23.4%. 48.9% of readmissions were due to decompensated heart failure. The in‐hospital mortality rate during readmissions was significantly higher than that of the index admission (5.6% vs. 2.4%; P < 0.05). The mean length of stay for patients during index admissions was 6.5 days (6.06–7.02), while during readmissions, it was 8.5 days (7.4–9.6; P < 0.05). The mean total hospitalization charges at index admissions were $78 438 (68 053–88 824), while during readmissions, they were higher at $124 282 (90 906–157 659; P < 0.05). The mean total cost of hospitalization during index admissions was $20 535 (18 311–22 758), while at readmissions, it was higher at $29 954 (24 041–35 867; P < 0.05). The total hospital charges for all 30 day readmissions were $195 million, and total hospital costs was $46.9 million. The variables found to be associated with increased rate of readmissions were patients with Medicaid insurance, higher Charlson co‐morbidity Index, and longer length of stay. The variables associated with lower rate of readmissions were prior percutaneous coronary intervention and patients with private insurance. Conclusions In patients with obstructive sleep apnoea admitted with heart failure with reduced ejection fraction, we found a substantial all‐cause readmission rate of 23.4% with heart failure readmission constituting about 48.9% of readmissions. Readmissions were associated with higher mortality and resource use.
first_indexed 2024-03-12T21:26:56Z
format Article
id doaj.art-c5a41a2834004f2da484e757873b20aa
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-03-12T21:26:56Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-c5a41a2834004f2da484e757873b20aa2023-07-28T06:30:48ZengWileyESC Heart Failure2055-58222023-08-011042534254010.1002/ehf2.14430Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fractionDon Mathew0Bhanu Kosuru1Siddharth Agarwal2Utsav Shrestha3Akil Sherif4Department of Internal Medicine University of Pittsburgh Medical Center (UPMC) Pittsburgh PA USADepartment of Internal Medicine University of Pittsburgh Medical Center (UPMC) Pittsburgh PA USADepartment of Internal Medicine University of Oklahoma Health Sciences Center Oklahoma City OK USADepartment of Pulmonary and Critical Care Medicine West Virginia University Morgantown WV USADepartment of Cardiology St Vincent Hospital Worcester MA USAAbstract Aims In this study, we estimated the 30 day all‐cause and heart failure‐specific readmission rates, predictors, mortality, and hospitalization costs in patients with obstructive sleep apnoea admitted with acute decompensated heart failure with reduced ejection fraction. Methods and results This is a retrospective cohort study using the Agency of Healthcare Research and Quality's National Readmission Database for the year 2019. The primary outcome was the 30 day all‐cause hospital readmission rate. The secondary outcomes were (i) in‐hospital mortality rate for index admissions; (ii) 30 day mortality rate for index hospitalizations; (iii) the five most common principal diagnosis for readmission; (iv) readmission in‐hospital mortality rate; (v) length of hospital stay; (vi) independent risk factors for readmission; and (vii) hospitalization costs. We identified 6908 hospitalizations that met our study definition. The mean patient age was 62.8 years, and women comprised only 27.6% of patients. The 30 day all‐cause readmission rate was 23.4%. 48.9% of readmissions were due to decompensated heart failure. The in‐hospital mortality rate during readmissions was significantly higher than that of the index admission (5.6% vs. 2.4%; P < 0.05). The mean length of stay for patients during index admissions was 6.5 days (6.06–7.02), while during readmissions, it was 8.5 days (7.4–9.6; P < 0.05). The mean total hospitalization charges at index admissions were $78 438 (68 053–88 824), while during readmissions, they were higher at $124 282 (90 906–157 659; P < 0.05). The mean total cost of hospitalization during index admissions was $20 535 (18 311–22 758), while at readmissions, it was higher at $29 954 (24 041–35 867; P < 0.05). The total hospital charges for all 30 day readmissions were $195 million, and total hospital costs was $46.9 million. The variables found to be associated with increased rate of readmissions were patients with Medicaid insurance, higher Charlson co‐morbidity Index, and longer length of stay. The variables associated with lower rate of readmissions were prior percutaneous coronary intervention and patients with private insurance. Conclusions In patients with obstructive sleep apnoea admitted with heart failure with reduced ejection fraction, we found a substantial all‐cause readmission rate of 23.4% with heart failure readmission constituting about 48.9% of readmissions. Readmissions were associated with higher mortality and resource use.https://doi.org/10.1002/ehf2.14430Heart failure with reduced ejection fractionHospitalization costObstructive sleep apnoeaReadmission rate
spellingShingle Don Mathew
Bhanu Kosuru
Siddharth Agarwal
Utsav Shrestha
Akil Sherif
Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
ESC Heart Failure
Heart failure with reduced ejection fraction
Hospitalization cost
Obstructive sleep apnoea
Readmission rate
title Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
title_full Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
title_fullStr Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
title_full_unstemmed Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
title_short Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
title_sort impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
topic Heart failure with reduced ejection fraction
Hospitalization cost
Obstructive sleep apnoea
Readmission rate
url https://doi.org/10.1002/ehf2.14430
work_keys_str_mv AT donmathew impactofsleepapnoeaon30dayhospitalreadmissionrateandcostinheartfailurewithreducedejectionfraction
AT bhanukosuru impactofsleepapnoeaon30dayhospitalreadmissionrateandcostinheartfailurewithreducedejectionfraction
AT siddharthagarwal impactofsleepapnoeaon30dayhospitalreadmissionrateandcostinheartfailurewithreducedejectionfraction
AT utsavshrestha impactofsleepapnoeaon30dayhospitalreadmissionrateandcostinheartfailurewithreducedejectionfraction
AT akilsherif impactofsleepapnoeaon30dayhospitalreadmissionrateandcostinheartfailurewithreducedejectionfraction